期刊文献+

表面抗原和抗体双阳性慢性乙型肝炎病毒感染者病毒S基因的变异分析 被引量:17

S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients
原文传递
导出
摘要 目的了解HBsAg和抗HBs双阳性慢性HBV感染者的S基因变异情况。方法分别对8例HBsAg和抗-HBs双阳性(实验组)及9例HBsAg阳性、抗-HBs阴性慢性}tBV感染者(对照组)的S基因进行PcR扩增并测序,将测序结果进行对比分析。基因型和血清型分布比较、主要亲水区变异位点数比较采用Fisher’s精确检验,核苷酸和氨基酸序列的同源性比较采用t检验。结果感染HBV的基因型分布:实验组为B型2例、C型6例,对照组为B型6例、C型3例,两组问差异无统计学意义(P〉0.05);血清型分布:实验组为adw2例、adr5例、ayr1例,对照组为adw6例、adr3例,两组问差异无统计学意义(P〉0.05)。实验组和对照组HBV前S1区的核昔酸替换率(2.29%比1.8%)和氨基酸替换率(2.66%比1.59%)差异无统计学意义(t值分别为1.56和1.39,P值均〉0.05);前S2区的核苷酸替换率(1.74%比0.91%)差异有统计学意义(t=4.68,P〈0.01),氨基酸替换率(3.18%比2.05%)差异无统计学意义(t=1.85,P〉0.05);S区的核苷酸替换率(2.13%比0.81%)和氨基酸替换率(4.37%比1.52%)差异有统计学意义(t值分别为6.00和5.32,P值均〈0.01)。主要亲水区内外均存在氨基酸的替换,“a”决定簇变异相对较高(P〈0.05)。结论HBsAg和抗-HBs双阳性慢性HBV感染者的S基因变异率相对较高。 Objective To investigate S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients. Methods HBV S gene from 8 patients (Group A) with HBsAg (+)/HBsAb (+) and 9 patients (Group B) with HBsAg (+)/HBsAb (-)was amplified by polymerase chain reaction (PCR) and sequencing. Both the distribution of genotype and serotype and the rate of MHR region were compared by Fisher's exact test. The mutation rate of both the DNA level and amino acid level was compared by t test. Results No significant difference in distribution of genotypes was found between the two groups (P = 0.153). In group A, 2 were genotype B, 6 were genotype C; In group B, 6 were genotype B, 3 were genotype C. No significant difference in distribution of serotypes was found between the two groups, either (P = 0.218). In group A, 2 were adw, 5 were adr, 1 was ayr; In group B, 6 were adw, 3 were adr. The mutation rate of Pre-S1 region at both the DNA level (2.29% vs 1.80%, t = 2.66, P 〉 0.05) and the amino acid level (2.66% vs 1.59%, t = 1.39, P 〉 0.05) was not significantly different between these two groups; ,the mutation rate of Pre-S2 region in group A patients was significantly higher than that in group B at the DNA level (1.74% vs 0.91%, t = 4.68, P 〈 0.01), but not higher at the amino acid level (3.18% vs 2.05%, t = 1.85, P 〉 0.05), the mutation rate of S region in group A patients was significantly higher than that in group B at both the DNA level (2.13% vs 0.81%, t = 6.00, P 〈 0.01) and the amino acid level (4.37% vs 1.52%, t = 5.32, P 〈 0.01). Amino acid substitutions were found both within and beyond the MHR region. The rate of "a" determinant mutations in these two groups was also found to be signicantly different (P 〈 0.05). Conclusion Higher HBV S gene mutation rate exists in HBsAg/HBsAb double positive pateints than that in HBsAg (+)/HBsAb (-) patients.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2009年第4期266-270,共5页 Chinese Journal of Hepatology
基金 国家重点基础研究发展计划(“973”计划)项目(2005CB522900) 安徽省教育厅基金(KJ2008B300)
关键词 肝炎病毒 乙型 肝炎表面抗原 乙型 突变 S基因 Hepatitis B virus Hepatitis B surface antigens Mutation S gene
  • 相关文献

参考文献9

  • 1Mathet VL, Feld M, Espfnola L, et al. Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating AntiHBs antibodies. J Med Virol, 2003, 69: 18-26.
  • 2Mesenas S J, Chow WC, Zhao Y, et al. Wild-type and ‘a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol, 2002, 17: 148-152.
  • 3Lada O, Benhamou Y, Poynard T, et al. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of ‘a’ determinant variants. J Virol, 2006, 80: 2968-2975.
  • 4Zheng X, Weinberger KM, Gehrke R, et al. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology, 2004, 329: 454-464.
  • 5Bartholomeusz A, Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol, 2004, 14: 3-16.
  • 6Zhang JM, Xu Y, Wang XY, et al. Coexistence of hepatitis B surface antigen (HBsAg) and heterologons subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis, 2007, 44: 1161-1169.
  • 7马世武,梁敏锋,于乐成,王战会,周彬,侯金林.我国主要乙型肝炎病毒流行株中C抗原18~27位细胞毒性T淋巴细胞表位特点分析[J].中华肝脏病杂志,2008,16(2):93-96. 被引量:3
  • 8Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology, 2001, 34: 1027-1034.
  • 9Liu C J, Kao JH, Shau WY, et al. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol, 2002, 68: 50-59.

二级参考文献10

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Zeng G, Wang Z, Wen S, et al. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat, 2005, 12: 609-617.
  • 3Wang Z, Hou J, Zeng G, et al. Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China. J Viral Hepat, 2007, 14: 426-434.
  • 4Kao JH, Chen PJ, Lai MY,et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology, 2000, 118: 554-559.
  • 5Norder H, Courouce AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology, 2004, 47: 289-309.
  • 6Bertoletti A, Chisari FV, Penna A, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol, 1993, 67: 2376-2380.
  • 7Bertoletti A, Costanzo A, Chisari FV, et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med, 1994, 180: 933-943.
  • 8Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med, 2000, 191: 1269-1280.
  • 9Whalley SA, Brown D, Webster GJ, et al. Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology, 2004, 127:1131-1138.
  • 10Peng M, Chen M, Ling N, et al. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70. Vaccine, 2006, 24: 887-896.

共引文献2

同被引文献111

引证文献17

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部